Palomino Laboratories Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-3.2M | $-16.2K | $-83.9K |
| Depreciation & Amortization | — | — | — |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $1.4M | — | — |
| Net Cash from Operating Activities | $-1.3M | $-4.9K | $-79.4K |
| Investing Activities | |||
| Capital Expenditures | — | — | — |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | — | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $9.3M | $195.4K | $79.3K |
| Net Change in Cash | $8.0M | $-4.9K | — |
| Free Cash Flow | — | — | — |